From Phase III Trials to Commercialization Partnerships, MindRank’s AI Drug Development Value Comes into Focus
TMX Group Equity Financing Statistics – September 2026
TMX Group Limited Announces Release Date for Q3 2026 Financial Results and Analyst Conference Call
GMG Announces 48% Increase in Energy Density, Doubling of Cycle Life and 94% Energy Efficiency for 6 Minute Fast Charge
DGTL Holdings Inc. Announces Failure-to-File Cease Trade Order
Dr. Bristow Dr. Michael Bristow, President and CEO, ARCA biopharma, Inc. Topline readout of clinical…
Preclinical data at World Vaccine & Immunotherapy Congress 2021 show broad immunogenicity and neutralization against…
TORONTO, Dec. 02, 2021 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB:…
– DYNE-251, Dyne’s First DMD Program, is Being Developed for Patients with Mutations Amenable to…
NDA resubmission expected in second calendar quarter 2022 (previously anticipated timeline)Final FDA decision expected 2 to…
PPF Group provides funding to advance SOTIO through key clinical milestones Proceeds shall be used…
SYDNEY, AUSTRALIA, Dec. 02, 2021 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep”…
BOTHELL, Wash., Dec. 02, 2021 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or…
Simcyp Simulator has been used to inform more than 250 label claims for 85+ novel…
WOBURN, Mass., Dec. 02, 2021 (GLOBE NEWSWIRE) — Replimune Group, Inc. (Nasdaq: REPL), a biotechnology…
Visionary technology investor Samuel Chen to join Board of Directors ALAMEDA, Calif., Dec. 02, 2021…
Grant of $400,000 to help expand sickle cell disease real-world data gathering in the U.S….
SEATTLE, Dec. 02, 2021 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage…
CAMBRIDGE, Mass., Dec. 02, 2021 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage…
BURBANK, Calif., Dec. 02, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Medolife Rx, Inc. (“Medolife”),…
BOSTON, Dec. 02, 2021 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE), a biotechnology…
Management will also host a webinar on Friday, December 10th at 2:00 p.m. ET NEW…
Aphria Branded Medical Cannabis Oral Strips Powered by QuickStrip™ Innovation Now Available to Patients Throughout…
Anticipate First Patient Dosing in Phase 1/2 Clinical Trial for XTX202, a Tumor-Selective IL-2, in…
AUSTIN, Texas, Dec. 02, 2021 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a…